Global Meningococcal Conjugate Market Research Report 2023

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

The global Meningococcal Conjugate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Meningococcal Conjugate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Meningococcal Conjugate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Meningococcal Conjugate in Children is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Meningococcal Conjugate include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Meningococcal Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Conjugate.

The Meningococcal Conjugate market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Meningococcal Conjugate market comprehensively. Regional market sizes, concerning products by type, by end user, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Meningococcal Conjugate companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by end user, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Menactra

1.2.3 Menveo

1.2.4 NeisVac-C

1.2.5 Nimenrix

1.2.6 Others

1.3 Market by End User

1.3.1 Global Meningococcal Conjugate Market Growth by End User: 2018 VS 2022 VS 2029

1.3.2 Children

1.3.3 Preteens or Teens

1.3.4 Adults

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Meningococcal Conjugate Market Perspective (2018-2029)

2.2 Meningococcal Conjugate Growth Trends by Region

2.2.1 Global Meningococcal Conjugate Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Meningococcal Conjugate Historic Market Size by Region (2018-2023)

2.2.3 Meningococcal Conjugate Forecasted Market Size by Region (2024-2029)

2.3 Meningococcal Conjugate Market Dynamics

2.3.1 Meningococcal Conjugate Industry Trends

2.3.2 Meningococcal Conjugate Market Drivers

2.3.3 Meningococcal Conjugate Market Challenges

2.3.4 Meningococcal Conjugate Market Restraints

3.1 Global Top Meningococcal Conjugate Players by Revenue

3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2018-2023)

3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2018-2023)

3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue

3.4 Global Meningococcal Conjugate Market Concentration Ratio

3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2022

3.5 Meningococcal Conjugate Key Players Head office and Area Served

3.6 Key Players Meningococcal Conjugate Product Solution and Service

3.7 Date of Enter into Meningococcal Conjugate Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Meningococcal Conjugate Historic Market Size by Type (2018-2023)

4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029)

5.1 Global Meningococcal Conjugate Historic Market Size by End User (2018-2023)

5.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029)

6.1 North America Meningococcal Conjugate Market Size (2018-2029)

6.2 North America Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Meningococcal Conjugate Market Size by Country (2018-2023)

6.4 North America Meningococcal Conjugate Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Meningococcal Conjugate Market Size (2018-2029)

7.2 Europe Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Meningococcal Conjugate Market Size by Country (2018-2023)

7.4 Europe Meningococcal Conjugate Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Meningococcal Conjugate Market Size (2018-2029)

8.2 Asia-Pacific Meningococcal Conjugate Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2023)

8.4 Asia-Pacific Meningococcal Conjugate Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Meningococcal Conjugate Market Size (2018-2029)

9.2 Latin America Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Meningococcal Conjugate Market Size by Country (2018-2023)

9.4 Latin America Meningococcal Conjugate Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Meningococcal Conjugate Market Size (2018-2029)

10.2 Middle East & Africa Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2023)

10.4 Middle East & Africa Meningococcal Conjugate Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Sanofi Pasteur

11.1.1 Sanofi Pasteur Company Detail

11.1.2 Sanofi Pasteur Business Overview

11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction

11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023)

11.1.5 Sanofi Pasteur Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Meningococcal Conjugate Introduction

11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2018-2023)

11.2.5 Pfizer Recent Development

11.3 Glaxo Smith Kline

11.3.1 Glaxo Smith Kline Company Detail

11.3.2 Glaxo Smith Kline Business Overview

11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction

11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023)

11.3.5 Glaxo Smith Kline Recent Development

11.4 Hualan Biological Engineering

11.4.1 Hualan Biological Engineering Company Detail

11.4.2 Hualan Biological Engineering Business Overview

11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction

11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023)

11.4.5 Hualan Biological Engineering Recent Development

11.5 JN International Medical Corporation

11.5.1 JN International Medical Corporation Company Detail

11.5.2 JN International Medical Corporation Business Overview

11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction

11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023)

11.5.5 JN International Medical Corporation Recent Development

11.6 Baxter International

11.6.1 Baxter International Company Detail

11.6.2 Baxter International Business Overview

11.6.3 Baxter International Meningococcal Conjugate Introduction

11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2018-2023)

11.6.5 Baxter International Recent Development

11.7 Merck

11.7.1 Merck Company Detail

11.7.2 Merck Business Overview

11.7.3 Merck Meningococcal Conjugate Introduction

11.7.4 Merck Revenue in Meningococcal Conjugate Business (2018-2023)

11.7.5 Merck Recent Development

11.8 Serum Institute of India

11.8.1 Serum Institute of India Company Detail

11.8.2 Serum Institute of India Business Overview

11.8.3 Serum Institute of India Meningococcal Conjugate Introduction

11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023)

11.8.5 Serum Institute of India Recent Development

11.9 Biomed

11.9.1 Biomed Company Detail

11.9.2 Biomed Business Overview

11.9.3 Biomed Meningococcal Conjugate Introduction

11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2018-2023)

11.9.5 Biomed Recent Development

11.10 Novartis

11.10.1 Novartis Company Detail

11.10.2 Novartis Business Overview

11.10.3 Novartis Meningococcal Conjugate Introduction

11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2018-2023)

11.10.5 Novartis Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Menactra

    Table 3. Key Players of Menveo

    Table 4. Key Players of NeisVac-C

    Table 5. Key Players of Nimenrix

    Table 6. Key Players of Others

    Table 7. Global Meningococcal Conjugate Market Size Growth by End User (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Meningococcal Conjugate Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Meningococcal Conjugate Market Share by Region (2018-2023)

    Table 11. Global Meningococcal Conjugate Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Meningococcal Conjugate Market Share by Region (2024-2029)

    Table 13. Meningococcal Conjugate Market Trends

    Table 14. Meningococcal Conjugate Market Drivers

    Table 15. Meningococcal Conjugate Market Challenges

    Table 16. Meningococcal Conjugate Market Restraints

    Table 17. Global Meningococcal Conjugate Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Meningococcal Conjugate Market Share by Players (2018-2023)

    Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)

    Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Meningococcal Conjugate Product Solution and Service

    Table 24. Date of Enter into Meningococcal Conjugate Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2018-2023)

    Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2024-2029)

    Table 30. Global Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)

    Table 31. Global Meningococcal Conjugate Revenue Market Share by End User (2018-2023)

    Table 32. Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029) & (US$ Million)

    Table 33. Global Meningococcal Conjugate Revenue Market Share by End User (2024-2029)

    Table 34. North America Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Meningococcal Conjugate Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Meningococcal Conjugate Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Sanofi Pasteur Company Detail

    Table 50. Sanofi Pasteur Business Overview

    Table 51. Sanofi Pasteur Meningococcal Conjugate Product

    Table 52. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 53. Sanofi Pasteur Recent Development

    Table 54. Pfizer Company Detail

    Table 55. Pfizer Business Overview

    Table 56. Pfizer Meningococcal Conjugate Product

    Table 57. Pfizer Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 58. Pfizer Recent Development

    Table 59. Glaxo Smith Kline Company Detail

    Table 60. Glaxo Smith Kline Business Overview

    Table 61. Glaxo Smith Kline Meningococcal Conjugate Product

    Table 62. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 63. Glaxo Smith Kline Recent Development

    Table 64. Hualan Biological Engineering Company Detail

    Table 65. Hualan Biological Engineering Business Overview

    Table 66. Hualan Biological Engineering Meningococcal Conjugate Product

    Table 67. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 68. Hualan Biological Engineering Recent Development

    Table 69. JN International Medical Corporation Company Detail

    Table 70. JN International Medical Corporation Business Overview

    Table 71. JN International Medical Corporation Meningococcal Conjugate Product

    Table 72. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 73. JN International Medical Corporation Recent Development

    Table 74. Baxter International Company Detail

    Table 75. Baxter International Business Overview

    Table 76. Baxter International Meningococcal Conjugate Product

    Table 77. Baxter International Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 78. Baxter International Recent Development

    Table 79. Merck Company Detail

    Table 80. Merck Business Overview

    Table 81. Merck Meningococcal Conjugate Product

    Table 82. Merck Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 83. Merck Recent Development

    Table 84. Serum Institute of India Company Detail

    Table 85. Serum Institute of India Business Overview

    Table 86. Serum Institute of India Meningococcal Conjugate Product

    Table 87. Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 88. Serum Institute of India Recent Development

    Table 89. Biomed Company Detail

    Table 90. Biomed Business Overview

    Table 91. Biomed Meningococcal Conjugate Product

    Table 92. Biomed Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 93. Biomed Recent Development

    Table 94. Novartis Company Detail

    Table 95. Novartis Business Overview

    Table 96. Novartis Meningococcal Conjugate Product

    Table 97. Novartis Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)

    Table 98. Novartis Recent Development

    Table 99. Research Programs/Design for This Report

    Table 100. Key Data Information from Secondary Sources

    Table 101. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Meningococcal Conjugate Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Meningococcal Conjugate Market Share by Type: 2022 VS 2029

    Figure 3. Menactra Features

    Figure 4. Menveo Features

    Figure 5. NeisVac-C Features

    Figure 6. Nimenrix Features

    Figure 7. Others Features

    Figure 8. Global Meningococcal Conjugate Market Size Comparison by End User (2023-2029) & (US$ Million)

    Figure 9. Global Meningococcal Conjugate Market Share by End User: 2022 VS 2029

    Figure 10. Children Case Studies

    Figure 11. Preteens or Teens Case Studies

    Figure 12. Adults Case Studies

    Figure 13. Meningococcal Conjugate Report Years Considered

    Figure 14. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Meningococcal Conjugate Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Meningococcal Conjugate Market Share by Region: 2022 VS 2029

    Figure 17. Global Meningococcal Conjugate Market Share by Players in 2022

    Figure 18. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2022

    Figure 20. North America Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Meningococcal Conjugate Market Share by Country (2018-2029)

    Figure 22. United States Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Meningococcal Conjugate Market Share by Country (2018-2029)

    Figure 26. Germany Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Meningococcal Conjugate Market Share by Region (2018-2029)

    Figure 34. China Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Meningococcal Conjugate Market Share by Country (2018-2029)

    Figure 42. Mexico Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Meningococcal Conjugate Market Share by Country (2018-2029)

    Figure 46. Turkey Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 49. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 50. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 51. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 52. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 53. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 54. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 55. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 56. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 57. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed